ClearanceBrief
Recall Z-0673-2019 ยท CDP Radioimmunoassay, Total Triiodothyronine

Tosoh Bioscience Inc

ST AIA-PACK FT3 (FT3: Free Triiodothyronine) is designed for IN VITRO DIAGNOSTIC USE ONLY for the quantitative measurement of Free Triiodothyronine (FT3) in human serum or heparinized plasma on specific Tosoh AIA System analyzers.

DateNov 30, 2018
StatusTerminated
Reason
Root causeDevice Design
ActionOn November 30, 2018, Tosoh Bioscience issued Urgent Medical Device Recall notices to customers. Customers are advised to take the following actions: " Do not use the assays identified in notice for those patients who have recently had a fluorescein angiography procedure. For these patients, use an alternative testing method that does not use a fluorescein-based technology. " Inform medical professionals that the Tosoh AIA assays in the notice utilize a fluorescein-based technology and should not be used to test patient samples for patients who have recently undergone fluorescein angiograph
Quantity24083 units
DistributionUS Nationwide
FDA recordOpen on fda.gov

510(k) clearances named in this recall

K963687AIA-PACK FT3 ASSAY
Tosoh Medics, Inc., Nov 8, 1996
K991252AIA-PACK FT3 ASSAY
Tosoh Medics, Inc., May 11, 1999